causal

Moderna Pursued Parallel Platform Applications

Moderna's strategy was to develop mRNA technology in parallel across rare diseases, oncology, and vaccines, because early on the engineering benefits were clearer than the medical ones, and vaccines were chosen as the straightest path to proving pharmacology.

causalpending

Speaker

Tal Zaks

Evidence Quote

“when it was clear early on that vaccine was the straightest shot to proving pharmacology of this technology, we went after vaccines. We didn't drop the other elements”

Source

Bridging Science, Medicine, and Returns— Invest Like the Best
Created: 11/19/2026, 4:01:33 PM

Your notes

Loading notes...